Literature DB >> 19195718

A follow-up study of chromosome 19q13 in multiple sclerosis susceptibility.

Alessandro Bonetti1, Keijo Koivisto, Tuula Pirttilä, Irina Elovaara, Mauri Reunanen, Mikko Laaksonen, Juhani Ruutiainen, Leena Peltonen, Terhi Rantamäki, Pentti J Tienari.   

Abstract

A possible role of allelic variation on chromosome 19q13 in multiple sclerosis (MS) susceptibility has been suggested. We tested association of sixteen 19q13 markers with MS in 459 families. Nominally significant associations were tested in an independent set of 323 families as well as in the pooled set of 782 families. We were not able to confirm previously suggested associations with APOE, GIPR, ZNF45, ILT6 and D19S585. In the screening dataset nominally significant associations were found with D19S867 and with APOE haplotype (p=0.007 in both), but these were not replicated in the independent dataset nor in the pooled analysis of 757 families. Thus, we were not able to detect any statistically significant allelic associations. Re-sequencing based approaches may be required for elucidating the role chromosome 19q13 with MS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19195718      PMCID: PMC2682252          DOI: 10.1016/j.jneuroim.2009.01.003

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  51 in total

Review 1.  Use of population isolates for mapping complex traits.

Authors:  L Peltonen; A Palotie; K Lange
Journal:  Nat Rev Genet       Date:  2000-12       Impact factor: 53.242

2.  A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission.

Authors:  D Clayton
Journal:  Am J Hum Genet       Date:  1999-10       Impact factor: 11.025

3.  Regional and temporal variation in the incidence of multiple sclerosis in Finland 1979-1993.

Authors:  M L Sumelahti; P J Tienari; J Wikström; J Palo; M Hakama
Journal:  Neuroepidemiology       Date:  2000 Mar-Apr       Impact factor: 3.282

4.  Juxtaposed regions of extensive and minimal linkage disequilibrium in human Xq25 and Xq28.

Authors:  P Taillon-Miller; I Bauer-Sardiña; N L Saccone; J Putzel; T Laitinen; A Cao; J Kere; G Pilia; J P Rice; P Y Kwok
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

5.  An attempt of identifying MS-associated loci as a follow-up of a genomic linkage study in the Italian population.

Authors:  S D'Alfonso; L Nisticò; D Bocchio; R Bomprezzi; M G Marrosu; M R Murru; M Lai; L Massacesi; C Ballerini; A Repice; M Salvetti; C Montesperelli; G Ristori; M Trojano; M Liguori; D Gambi; A Quattrone; R Tosi; P Momigliano-Richiardi
Journal:  J Neurovirol       Date:  2000-05       Impact factor: 2.643

6.  A genome screen for multiple sclerosis in Italian families.

Authors:  S Broadley; S Sawcer; S D'Alfonso; A Hensiek; F Coraddu; J Gray; R Roxburgh; D Clayton; C Buttinelli; A Quattrone; M Trojano; L Massacesi; A Compston
Journal:  Genes Immun       Date:  2001-06       Impact factor: 2.676

7.  Linkage analysis in multiple sclerosis of chromosomal regions syntenic to experimental autoimmune disease loci.

Authors:  C Xu; Y Dai; J C Lorentzen; I Dahlman; T Olsson; J Hillert
Journal:  Eur J Hum Genet       Date:  2001-06       Impact factor: 4.246

8.  Sequence variation in the transforming growth factor-beta1 (TGFB1) gene and multiple sclerosis susceptibility.

Authors:  A J Green; L F Barcellos; J B Rimmler; M E Garcia; S Caillier; R R Lincoln; P Bucher; M A Pericak-Vance; J L Haines; S L Hauser; J R Oksenberg
Journal:  J Neuroimmunol       Date:  2001-05-01       Impact factor: 3.478

9.  Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts.

Authors:  J Paloneva; M Kestilä; J Wu; A Salminen; T Böhling; V Ruotsalainen; P Hakola; A B Bakker; J H Phillips; P Pekkarinen; L L Lanier; T Timonen; L Peltonen
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

10.  No evidence for shared etiology in two demyelinative disorders, MS and PLOSL.

Authors:  Anna-Maija Sulonen; Suvi P Kallio; Pekka Ellonen; Minna Suvela; Irina Elovaara; Keijo Koivisto; Tuula Pirttilä; Mauri Reunanen; Pentti J Tienari; Aarno Palotie; Leena Peltonen; Janna Saarela
Journal:  J Neuroimmunol       Date:  2008-11-18       Impact factor: 3.478

View more
  7 in total

1.  IRF3 polymorphisms induce different innate anti-Theiler's virus immune responses in RAW264.7 macrophages.

Authors:  Tyler C Moore; Fahd M Al-Salleeh; Deborah M Brown; Thomas M Petro
Journal:  Virology       Date:  2011-08-02       Impact factor: 3.616

2.  An ADIOL-ERβ-CtBP transrepression pathway negatively regulates microglia-mediated inflammation.

Authors:  Kaoru Saijo; Jana G Collier; Andrew C Li; John A Katzenellenbogen; Christopher K Glass
Journal:  Cell       Date:  2011-05-13       Impact factor: 41.582

Review 3.  The immune-modulatory role of apolipoprotein E with emphasis on multiple sclerosis and experimental autoimmune encephalomyelitis.

Authors:  Hong-Liang Zhang; Jiang Wu; Jie Zhu
Journal:  Clin Dev Immunol       Date:  2010-05-31

Review 4.  Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects.

Authors:  Anna J Khalaj; Jonathan Hasselmann; Catherine Augello; Spencer Moore; Seema K Tiwari-Woodruff
Journal:  J Steroid Biochem Mol Biol       Date:  2016-01-14       Impact factor: 4.292

5.  LILRA3 binds both classical and non-classical HLA class I molecules but with reduced affinities compared to LILRB1/LILRB2: structural evidence.

Authors:  Myongchol Ryu; Yong Chen; Jianxun Qi; Jun Liu; Zheng Fan; Gol Nam; Yi Shi; Hao Cheng; George F Gao
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

6.  Influence of the LILRA3 Deletion on Multiple Sclerosis Risk: Original Data and Meta-Analysis.

Authors:  Miguel A Ortiz; Concepción Núñez; David Ordóñez; José C Alvarez-Cermeño; José E Martínez-Rodriguez; Antonio J Sánchez; Rafael Arroyo; Guillermo Izquierdo; Sunny Malhotra; Xavier Montalban; Antonio García-Merino; Elvira Munteis; Antonio Alcina; Manuel Comabella; Fuencisla Matesanz; Luisa M Villar; Elena Urcelay
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

7.  Serum Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3) Is Increased in Patients with Multiple Sclerosis and Is a Strong Independent Indicator of Disease Severity; 6.7kbp LILRA3 Gene Deletion Is Not Associated with Diseases Susceptibility.

Authors:  Hongyan An; Chai Lim; Gilles J Guillemin; Ute Vollmer-Conna; William Rawlinson; Katherine Bryant; Nicodemus Tedla
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.